Cathie Wood’s ARK Invest Sells Over 300,000 Shares of Iovance Bio
One of Cathie Wood's ARK Invest funds sold over 300,000 shares of cancer-focused biopharma startup Iovance Bio on August 26.
One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Thursday. This fund sold over 300,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA | IOVA Price Prediction) shares, as the price of this ETF was down over 1% on Thursday. Note that this fund is still up handily in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Thursday’s closing price, this would have valued this sale at $7.0 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 36% in the past year.
Check out all of the ARK Invest sales for Thursday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 4477JP | BASE | 22,900 |
| ARKF | GOOG | ALPHABET | 131 |
| ARKF | 9923HK | YEAHKA | 252,800 |
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 638,800 |
| ARKG | BMY | BRISTOL-MYERS SQUIBB | 29,000 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 15,505 |
| ARKG | RHHBY | ROCHE | 32,600 |
| ARKG | MCRB | SERES THERAPEUTICS | 400 |
| ARKG | SEER | SEER | 20,000 |
| ARKK | NSTG | NANOSTRING TECHNOLOGIES | 144,340 |
| ARKK | NTDOY | NINTENDO | 38,500 |
| ARKK | SE | SEA | 71,593 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 302,190 |
| ARKQ | BABA | ALIBABA | 46,900 |
| ARKQ | XONE | EXONE | 10,000 |
| ARKW | LC | LENDINGCLUB | 32,700 |
| ARKW | OKTA | OKTA | 31,041 |
| ARKW | SQ | SQUARE | 21,732 |
| ARKX | TRMB | TRIMBLE | 9,167 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=942416][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
